1. MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1
   Hui Liu et al, 2018, Oncotarget CrossRef
2. Identification of a Novel Genetic Signature in Staging of Colorectal Cancer: A Bayesian Approach
   Fatemeh Mohammadzadeh et al, 2019, Iranian Red Crescent Medical Journal CrossRef
3. Oxaliplatin induces ferroptosis and oxidative stress in HT29 colorectal cancer cells by inhibiting the Nrf2 signaling pathway
   Ben Liu et al, 2022, Experimental and Therapeutic Medicine CrossRef
4. IFI6 Downregulation Reverses Oxaliplatin Resistance of Colorectal Cancer Cells by Activating the ROS-Induced p38MAPK Signaling Pathway
   Chen Huang et al, 2023, Biological and Pharmaceutical Bulletin CrossRef
5. Flavopereirine Suppresses the Growth of Colorectal Cancer Cells through P53 Signaling Dependence
   Jhy-Ming Li et al, 2019, Cancers CrossRef
6. Analysis of microarray-identified genes and MicroRNAs associated with Trifluridine resistance in colorectal cancer
   Qiqi Zhang et al, 2022, All Life CrossRef
7. Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling
   Yujia Zhang et al, 2022, Stem Cell Research & Therapy CrossRef
8. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin
   Changshun Yang et al, 2021, Aging CrossRef
9. Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
   Xuan Liu et al, 2022, Frontiers in Pharmacology CrossRef
10. Role of ferroptosis in colorectal cancer
    Ya-Qi Song et al, 2023, World Journal of Gastrointestinal Oncology CrossRef